DG Capital Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by DG Capital Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by DG Capital Management from 13F filings

Historical chart of DG Capital Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by DG Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by DG Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $19M 22M 0.88

More positions owned by DG Capital Management

Mercury General Corporation (MCY)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Burford Cap Ord Shs (BUR)
Geo Group Inc/the reit Call Option (GEO)
Sarepta Therapeutics Note 1.250% 9/1 (Principal)
Caesars Entertainment (CZR)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Anterix Inc. Atex (ATEX)
Magnera Corp Com Shs (MAGN)
United Ins Hldgs (ACIC)
Genesis Energy Unit Ltd Partn (GEL)
Corecivic Call Option (CXW)
Golar Lng SHS (GLNG)
Capricor Therapeutics Com New (CAPR)
Xponential Fitness Com Cl A (XPOF)

View all positions for DG Capital Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Balyasny Asset Management
Linden Advisors
Highbridge Capital Management
Oaktree Capital Management
D. E. Shaw & Co
DG Capital Management
Calamos Advisors
Davidson Kempner Capital Management
Agf Management
Readystate Asset Management
LMR Partners
State Street Corporation
Silver Point Capital
Man Group
Capstone Investment Advisors

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1